Hemofilia adquirida - A propósito de um caso clínico
Palavras-chave:
hemofilia adquirida, inibidor de factor VIII, discrasia hemorrágicaResumo
O desenvolvimento espontâneo de auto-anticorpos contra o factor VIII da coagulação em doentes não hemofílicos é uma entidade rara, mas clinicamente significante pelas suas complicações hemorrágicas.
A associação da hemofilia adquirida com doenças benignas e malignas esta descrita, mas na maioria dos casos não é possível identificar qualquer causa precipitante.
Os autores apresentam uma revisão sumária desta patologia, ilustrando-a com um caso clínico de um doente de 73 anos, do sexo feminino, internado por quadro de discrasia hemorrágica grave.
Downloads
Referências
Green D. Lechner K. A survey of 215 non-hemophilic patient with inhibitors to factor Vlll.Thromh Haemost 1981;45:200- 20.1.
Lusher JM. Acquired inhihitors to factor VIII in non-hemophilic patients. ln: Craij Kessler, ed,. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995:1-8.
Kessler CM: An introduction to factor VIII inhibitors: the detection and quantitation. AmJ Med 199l;vol 91.suppl 5A: 1-5.
Green D. Acquired Factor VIII Inhibitors and immunosuppression of autoantibodies. ln: Craij Kessler, eds. Acquired Hemo philia 2nd ed. Princeton.Excerpta Medica lnc. l995;25-40.
Hoyer LW, Scandella D: Factor VIII inhibitors :structure and function in autoantibody and hemophilia A patient. Seminars in Hematology 1994; 2(2) 4:1-5.
Hltin MB: Acquired inhihitors in malignant and nonmalignant disease states. Am J Med 1991:vol 91.suppl 5A:9-13.
Garvey MH: lncidence and management of patients with acquired factor VIII inhibitors: The practical experience of a tertiary care Hospital. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica lnc. 1995;91-111.
Ludbm CA, Morrison AE, Kessler C. Treatment of acquired hemophilia. Seminars in Hematology 1994; 2(2) 4:16-19.
Kasper CK. Lahoratory diagnosis of factor VIII inhibitors. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica lnc. 1995:9-23.
Green D: Cytotoxic suppression of acquired factor VIIl:C inhibitors. Am.J Med 1991; 91(suppl 5A) 14-19.
Kasper CK. Raising factor VIII leveis in patients with acquired factor VIII inhibitors. ln: Craij Kessler, ecb. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica lnc. 1995;41-69.
Kernoff PBA. Rationale and evolution of therapy with porcine factor VIII:C. Am J Med 1991;9l(suppl 5A):20-22.
Kernoff PBA. Thomas ND, Lilley PA et ai. Clinicai experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII. Blood 1984; 63:31-41.
Hay CRM, Bolton-Maggs P: Porcine factor VIII in the management of patients with factor VIII inhihitors. Transfusion Med Rev 1991; vol V(2):145-151.
Kessler CM. The treatment of acquired factor VIII inhibitors: Worldwide experience with porcine factor VIII. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995;71-89.
Negrier C. The use of porcine factor VIII in France. Seminars in Hematology 1994; 2 (2) 4:29-32.
Kessler CM. Factor VIII inhihitors-an algorithmic approach to treatment. Seminars in Hematology 1994; 2(2) 4:33-36.
Lusher JM. Use of factor VIII bypassing agents to control bleeding in patients with acquired factor VIII inhib itors. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995; 115-129.
Lusher JM. l'erspectives on the use of factor IX complex conentrates in the treatment of bleeding in persons with acquired factor VIII inhibition. Am.J Med 1991;91Csuppl 5A):30-34.
Schwartz RS, Gabriel DA, Aledort LM et ai. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with intravenous gammaglobulin. Blood 1995; 86:797- 804.
Sultan Y, Maisonneuve P, Kazatchkine MD, Nydegger UE: Anti idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglohulin. Lancet 1984; 2:765-768.
Sultan Y, Kazatchkine MD e al. Intravenous immunoglohulin in the treatment of spontaneously acquired factor VIII:C inhibitors. Am J Med 1991;91(suppl 5A):35-39.
Sultan Y, Kazatchkine et al. The use of immunoglobulins in the treatment of factor VIII inhibitors. Seminars in Hematology 1994;2(2) 4:65-66.
Green D. lmmunosuppression of patients with acquired factor VIII inhibitors. Seminars in Hematology 1994;2(2) 4:60-61.
Lian ECY, Larcada AF, Chiu AYZ. Combination immunisuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann lntern Med 1989; 110: 774-778.
Kasper CK. Algorithm for management of patients with acqui red hemophilia. ln: Craij Kessler, eds. Acquired Hemophilia 2nd ed. Princeton. Excerpta Medica Inc. 1995;149-153.
Hoyer LW. Future approaches to factor VIII inhibitors therapy. AmJ Med 1991;91(suppl SA):40-44.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
